MetLife, Inc.
MET
$81.94
-$1.13-1.35%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.75% | 5.14% | -2.17% | -0.03% | -1.07% |
| Total Other Revenue | 148.30% | 171.20% | 30.09% | -109.90% | -135.48% |
| Total Revenue | 6.10% | 12.39% | -1.61% | -1.71% | -2.71% |
| Cost of Revenue | 0.81% | 6.84% | -4.16% | -0.96% | -2.20% |
| Gross Profit | 26.32% | 32.41% | 8.37% | -4.51% | -4.60% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -17.20% | -16.29% | -15.23% | -14.37% | 32.48% |
| Total Operating Expenses | 1.15% | 6.34% | -2.46% | 0.46% | -0.69% |
| Operating Income | 151.25% | 171.32% | 17.19% | -41.03% | -39.05% |
| Income Before Tax | 160.04% | 59.59% | -9.84% | -37.05% | -66.03% |
| Income Tax Expenses | 110.36% | 106.34% | -11.50% | -40.51% | -47.27% |
| Earnings from Continuing Operations | 177.40% | 47.26% | -9.38% | -36.18% | -69.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.00% | -5.00% | -47.37% | -50.00% | -33.33% |
| Net Income | 180.48% | 47.59% | -9.71% | -36.60% | -70.14% |
| EBIT | 151.25% | 171.32% | 17.19% | -41.03% | -39.05% |
| EBITDA | 113.98% | 134.92% | 15.33% | -33.49% | -31.88% |
| EPS Basic | 226.16% | 64.25% | -3.31% | -34.37% | -71.03% |
| Normalized Basic EPS | 180.89% | 74.07% | -2.98% | -33.08% | -64.19% |
| EPS Diluted | 226.36% | 64.27% | -3.12% | -34.30% | -70.98% |
| Normalized Diluted EPS | 180.76% | 74.16% | -2.93% | -33.04% | -64.15% |
| Average Basic Shares Outstanding | -6.77% | -6.67% | -6.33% | -5.88% | -5.67% |
| Average Diluted Shares Outstanding | -6.72% | -6.66% | -6.36% | -5.95% | -5.75% |
| Dividend Per Share | 4.61% | 4.41% | 4.21% | 4.00% | 4.04% |
| Payout Ratio | -0.65% | -0.33% | 0.09% | 0.56% | 2.31% |
